Penumbra, Inc. Schedules First Quarter 2021 Earnings Release and Conference Call for May 4, 2021
Penumbra, Inc. (NYSE: PEN) has announced a conference call to discuss its financial results for Q1 2021, scheduled for May 4, 2021, at 4:30 PM ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Penumbra, Inc. (NYSE: PEN) has announced a conference call to discuss its financial results for Q1 2021, scheduled for May 4, 2021, at 4:30 PM ET. The results will be released after market close on the same day. Investors can join the call by dialing (833) 350-1434 or accessing the webcast on the company’s website. Further information about Penumbra, a global healthcare company focused on innovative therapies, can be found on its website.
Positive
- Scheduled conference call indicates transparency and communication with investors.
Negative
- None.
Details
News Market Reaction – PEN
The recorded move for PEN in the trading session of this news was -0.99%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ALAMEDA, Calif., April 13, 2021 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the first quarter 2021 after market close on Tuesday, May 4, 2021 at 4:30 PM Eastern Time. A press release with first quarter 2021 financial results will be issued after market close that day.
Webcast & Conference Call Information
The conference call can be accessed live over the phone by dialing (833) 350-1434 for domestic and international callers (conference id: 6645719), or the webcast can be accessed on the "Events" section under the "Investors" tab of the Company's website at: www.penumbrainc.com. The webcast will be available on the Company's website for at least two weeks following the completion of the call.
About Penumbra
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need. Penumbra sells its products to hospitals and healthcare providers primarily through its direct sales organization in the United States, most of Europe, Canada and Australia, and through distributors in select international markets. The Penumbra logo is a trademark of Penumbra, Inc. For more information, visit www.penumbrainc.com.
Investor Relations
Penumbra, Inc.
510-995-2461
investors@penumbrainc.com
Source: Penumbra, Inc.
View original content to download multimedia:http://www.prnewswire.com/news-releases/penumbra-inc-schedules-first-quarter-2021-earnings-release-and-conference-call-for-may-4-2021-301266073.html
SOURCE Penumbra, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.